Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolapitant IV SAD in Healthy Volunteers
NCT02382666Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rolapitant in chemotherapy-induced nausea and vomiting (CINV) (6 cohorts). Primary endpoint: Safety and Tolerability (adverse events). Started Jan 2015; status: completed.
02
Drugs
rolapitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02382666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382666.